Abstract
The attainment of synchronous follicular development in human menopausal gonadotropin/human chorionic gonadotropin-stimulated cycles for in vitro fertilization (IVF) continues to be a perplexing problem. Two regimens of follicle stimulation for IVF cycles were, therefore, compared. Twenty-nine patients commenced human menopausal gonadotropin (hMG) therapy on day I of the menstrual cycle (Group I), while 30 women received hMG from the third day of the cycle (Group II). The hMG therapy was tailored to the individual patients's response, based on ultrasonographic measurements of follicular size and serum estradiol (E2) levels. Both groups of patients received a mean of 19.6±1.4 ampules of hMG over a mean of 6.1±0.2 days. The pattern of serum E2 and progesterone levels in the periovulatory and luteal phase was not affected by the day of initiation of hMG therapy, although Group I patients demonstrated lower (P<0.05) E2 levels on the 2 days prior to human chorionic gonadotropin (hCG) administration. In terms of follicle growth, Group II follicles consistently demonstrated a significantly (P<0.01,x 2 test) larger proportion of medium- and large-sized follicles compared to Group I follicles on almost all of the days when ultrasonographic measurements were taken. In addition. Group II follicles demonstrated an earlier shift (day—1) to the larger follicles than Group I follicles (day 0). Significantly (P<0.001) more oocytes were recovered per uspirated follicle in Group II patients, but the fertilization rate per oocyte was greater (P<0.003) for Group I oocytes. Nevertheless, pregnancy rates did not differ between the two groups. It is suggested that a difference between the two groups of patients in the quantity or quality of gonadotropin receptor sites in the early part of the follicular phase may account for both the diminished E2 production in the follicular phase and the persistent depressed follicular growth in Group I patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hodgen GD: The dominant ovarian follicle. Fertil Steril 1982;38:281
Steptoe PC, Edwards RG: Birth after the implantation of a human embryo. Lancet 1978;2:366
Trousan AO, Mohr LR, Wood C, Leeton JF: The effect of delayed insemination of in vitro fertilization. J Reprod Fertil 1982;64:285
Jones HW Jr, Jones GS, Andrews MD, Acosta A, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14
Edwards RG, Purdy JM: Human Conception in Vitro. London, Academic Press, 1982
Laufer N, Reich A, Braw R, Schenker JG, Tsafriri A: The effect of clomiphene citrate on preovulatory rat follicles in culture. Biol Reprod 1982;27:463
Laufer N, Pratt BM, DeCherney AH, Naftolin F, Merino M, Markert CL: The in vivo and in vitro effects of clomiphene citrate on ovulation, fertilization, and development of cultured mouse oocytes. Am J Obstet Gynecol 1983;147:633
Marut EL, Hodgen GD: Antiestrogenic action of high-dose clomiphene in primates: Pituitary augmentation but with ovarian attenuation. Fertil Steril 1982;38:100
Dlugi AM, Laufer N, Botero-Ruiz W, DeCherney AH, Polan ML, Haseltine FP, Mezer HC, Behrman HR: Altered follicular development in clomiphene-citrate vs. human menopausal gonadotropin-stimulated cycles for in vitro fertilization. Fertil Steril (in press)
Olsono JL, Rebar RW, Schreiber JR, Vaitukaitis Jl: Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril 1983;39:284
Dlugi AM, Laufer N, DeCherney AH, MacLusky NJ, Haseltine FP, Polan ML, Mezer HC, Tarlatzis BC, Naftolin F: The periovulatory and luteal phase of conception cycles following in vitro fertilization. Fertil Steril 1984;41:530
Fowler RE, Edwards RG, Walters DE, Chan ST, Stepoee PC: Steroidogenesis in preovulatory follicles of patients given human menopausal and chorionic gonadotropin as judged by the radioimmunoassay of steroids in follicular fluid. J Endocrinol 1978;77:161
Laufer N, Tarlatzis BC, DeCherney AH, MacLusky NJ, Naftolin F: Asynchrony between human cumulus-coronacell-complex and oocyte maturation after human menopausal gonadotropin treatment for in vitro fertilization. Fertil Steril 1984;42:366
Testart J, Frydman R, DeMouzon J, Larale B, Belaisch JC. A study of factors affecting the success of human fertilization in vitro. Influence of ovarian stimulation upon the number and condition of oocytes collected. Biol Reprod 1983;28:415
Laufer N, DeCherney AH, Haseltine FP, Polan ML, Mezer HC, Dlugi AM, Sweeney D, Nero F, Naftolin F: The use of high dose menopausal gonadotropin in an in vitro fertilization program. Fertil Steril 1983;40:734
Dlugi AM, Laufer N, Polan ML, DeCherney AH, Tarlatzis BC, MacLusky NJ, Behrman HR: 17β-estradiol and progesterone production by human granulosaluteal cells isolated from human menopausal gonadotropin-stimulated cycles for in vitro fertilization. J Clin Endocrinol Metab 1984;59:986
DeCherney AH, Sadovsky Y, Laufer N, Tarlatzis B, Haseltine FP, Polan ML: The relationship between follicular fluid aspirated volume (FFV) and oocyte quality in human menopausal gonadotropin (hMG)-induced cycles for in vitro fertilization (IVF). J Vitro Fert Embryo Transfer 1984;1:105
Peters H, Byskov AG, Himelstein BR, Faber M: Follicular growth: The basic event in the mouse and human ovary. J Reprod Fertil 1975;45:559
Braw RH, Tsafriri A: Effect of PMSG on follicular atresin in the immature rat ovary. J Repord Fertil 1980;59:267
Laufer N, DeCherney AH, Tarlatzis BC, Zuckerman AL, Polan ML, Dlugi AM, Graebe R, Barnea ER, Naftolin F, Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes. Ferti Steril 1984;42:198
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dlugi, A.M., Laufer, N., Decherney, A.H. et al. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro fertilization cycles. J Assist Reprod Genet 2, 33–40 (1985). https://doi.org/10.1007/BF01130830
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01130830